Warrants Finder
Your selection:
898 Results
| GU8BUX | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 49.215% | 0.090 | -0.007 | 7.726 | 12/18/2026 | 0.010 | Goldman Sachs | ||
| GU8BWA | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.967% | 0.097 | -0.007 | 7.502 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW33VD | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.620% | 0.261 | -0.007 | 4.167 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW43BF | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.674% | 0.108 | -0.006 | 7.174 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW9D3Y | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.306% | 0.303 | -0.006 | 3.735 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| GW9D43 | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.539% | 0.146 | -0.006 | 6.167 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| GN02D2 | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.448% | 0.038 | -0.004 | 10.834 | 11/20/2026 | 0.010 | Goldman Sachs | ||
| GN07V4 | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 53.559% | 0.045 | -0.006 | 10.220 | 10/16/2026 | 0.010 | Goldman Sachs | ||
| MJ3USJ |  | Regeneron Pharmaceuticals Inc./OS/Call [1100]/MS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 53.960% | 0.114 | -0.009 | 6.828 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM7L6Y | | Regeneron Pharmaceuticals Inc./OS/Call [1100]/MS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 80.568% | 0.090 | -0.018 | 7.555 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MM7L6X | | Regeneron Pharmaceuticals Inc./OS/Call [1100]/MS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.722% | 0.189 | -0.008 | 5.237 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MN5WX2 | | Regeneron Pharmaceuticals Inc./OS/Call [1100]/MS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.972% | 0.286 | -0.008 | 3.850 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MN6F4H | | Regeneron Pharmaceuticals Inc./OS/Call [1100]/MS | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.985% | 0.146 | -0.008 | 6.076 | 03/19/2027 | 0.010 | Morgan Stanley | |
| FD442N | Regeneron Pharmaceuticals Inc./OS/Call [1100]/SOC | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.494% | 0.036 | -0.027 | 11.121 | 12/18/2026 | 0.100 | Société Générale | ||
| FD51R4 | Regeneron Pharmaceuticals Inc./OS/Call [1100]/SOC | - | - | 1,100.000 | call | Regeneron Pharmaceuticals Inc. | - | 36.565% | 0.130 | -0.050 | 6.613 | 06/17/2027 | 0.100 | Société Générale | ||
| GJ50FT | Regeneron Pharmaceuticals Inc./OS/Call [1150]/GOLDS | - | - | 1,150.000 | call | Regeneron Pharmaceuticals Inc. | - | 75.677% | 0.057 | -0.012 | 8.605 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GW4RET | Regeneron Pharmaceuticals Inc./OS/Call [1150]/GOLDS | - | - | 1,150.000 | call | Regeneron Pharmaceuticals Inc. | - | 48.193% | 0.088 | -0.006 | 7.331 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW6BNJ | Regeneron Pharmaceuticals Inc./OS/Call [1150]/GOLDS | - | - | 1,150.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.521% | 0.104 | -0.006 | 6.803 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| PL1GG9 | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/BNP | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 59.070% | 0.099 | -0.009 | 6.472 | 12/18/2026 | 0.010 | BNP Paribas | |
| PL1LRQ | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/BNP | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 53.960% | 0.100 | -0.008 | 6.496 | 01/15/2027 | 0.010 | BNP Paribas | |
| GJ50F7 | Regeneron Pharmaceuticals Inc./OS/Call [1200]/GOLDS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 80.568% | 0.054 | -0.012 | 8.199 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GJ91XL | Regeneron Pharmaceuticals Inc./OS/Call [1200]/GOLDS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 51.551% | 0.064 | -0.006 | 7.856 | 12/18/2026 | 0.010 | Goldman Sachs | ||
| GU7EE1 | Regeneron Pharmaceuticals Inc./OS/Call [1200]/GOLDS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 50.274% | 0.080 | -0.006 | 7.177 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW01CC | Regeneron Pharmaceuticals Inc./OS/Call [1200]/GOLDS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.547% | 0.209 | -0.006 | 4.418 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW43E3 | Regeneron Pharmaceuticals Inc./OS/Call [1200]/GOLDS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.054% | 0.093 | -0.006 | 6.738 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW5EBH | Regeneron Pharmaceuticals Inc./OS/Call [1200]/GOLDS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 111.446% | 0.053 | -0.020 | 8.206 | 08/21/2026 | 0.010 | Goldman Sachs | ||
| MJ3USK | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/MS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 59.909% | 0.101 | -0.010 | 6.380 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM8JYR | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/MS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 46.259% | 0.157 | -0.007 | 5.209 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM8JYS | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/MS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 90.788% | 0.082 | -0.019 | 6.909 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN6F4J | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/MS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 49.799% | 0.124 | -0.008 | 5.868 | 03/19/2027 | 0.010 | Morgan Stanley | |
| MN8MD8 | | Regeneron Pharmaceuticals Inc./OS/Call [1200]/MS | - | - | 1,200.000 | call | Regeneron Pharmaceuticals Inc. | - | 46.277% | 0.245 | -0.008 | 3.927 | 12/17/2027 | 0.010 | Morgan Stanley | |
| GJ50F3 | Regeneron Pharmaceuticals Inc./OS/Call [1250]/GOLDS | - | - | 1,250.000 | call | Regeneron Pharmaceuticals Inc. | - | 88.817% | 0.063 | -0.015 | 7.347 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GW5E6X | Regeneron Pharmaceuticals Inc./OS/Call [1250]/GOLDS | - | - | 1,250.000 | call | Regeneron Pharmaceuticals Inc. | - | 52.464% | 0.074 | -0.006 | 6.997 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GJ50EZ | Regeneron Pharmaceuticals Inc./OS/Call [1300]/GOLDS | - | - | 1,300.000 | call | Regeneron Pharmaceuticals Inc. | - | 93.270% | 0.061 | -0.015 | 7.079 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GW3163 | Regeneron Pharmaceuticals Inc./OS/Call [1300]/GOLDS | - | - | 1,300.000 | call | Regeneron Pharmaceuticals Inc. | - | 54.690% | 0.070 | -0.006 | 6.814 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW3196 | Regeneron Pharmaceuticals Inc./OS/Call [1300]/GOLDS | - | - | 1,300.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.372% | 0.180 | -0.006 | 4.415 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW4NH6 | Regeneron Pharmaceuticals Inc./OS/Call [1300]/GOLDS | - | - | 1,300.000 | call | Regeneron Pharmaceuticals Inc. | - | 48.339% | 0.079 | -0.005 | 6.519 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GV7ABM | Regeneron Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Regeneron Pharmaceuticals Inc. | - | 58.705% | 0.945 | -0.008 | 2.220 | 12/18/2026 | 0.010 | Goldman Sachs | ||
| PJ2446 | | Regeneron Pharmaceuticals Inc./OS/Call [450]/BNP | - | - | 450.000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1.000 | 0.000 | 3.000 | 09/18/2026 | 0.010 | BNP Paribas | |
| PJ2447 | | Regeneron Pharmaceuticals Inc./OS/Call [450]/BNP | - | - | 450.000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1.000 | 0.000 | 3.000 | 12/18/2026 | 0.010 | BNP Paribas | |
| PJ2448 | | Regeneron Pharmaceuticals Inc./OS/Call [450]/BNP | - | - | 450.000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1.000 | 0.000 | 2.996 | 01/15/2027 | 0.010 | BNP Paribas | |
| PG10X4 | | Regeneron Pharmaceuticals Inc./OS/Call [500]/BNP | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1.000 | 0.000 | 3.849 | 12/18/2026 | 0.010 | BNP Paribas | |
| PG10X7 | | Regeneron Pharmaceuticals Inc./OS/Call [500]/BNP | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.434% | 0.880 | -0.010 | 2.995 | 01/15/2027 | 0.010 | BNP Paribas | |
| PG10XU | | Regeneron Pharmaceuticals Inc./OS/Call [500]/BNP | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1.000 | 0.000 | 3.849 | 09/18/2026 | 0.010 | BNP Paribas | |
| PJ912S | | Regeneron Pharmaceuticals Inc./OS/Call [500]/BNP | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.730% | 0.852 | -0.009 | 2.755 | 03/19/2027 | 0.010 | BNP Paribas | |
| GV4SSA | Regeneron Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.485% | 0.896 | -0.009 | 3.138 | 12/18/2026 | 0.010 | Goldman Sachs | ||
| GV70F1 | Regeneron Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 47.135% | 0.955 | -0.009 | 3.577 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GU3QN8 | Regeneron Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 47.135% | 0.955 | -0.009 | 3.577 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GU3T4J | Regeneron Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.795% | 0.882 | -0.010 | 3.016 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW7KCB | Regeneron Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Regeneron Pharmaceuticals Inc. | - | 46.204% | 0.811 | -0.007 | 2.192 | 01/21/2028 | 0.010 | Goldman Sachs |